Similar Papers

Paper Title
Journal
Date
Author
Lung Cancer: The Past Twenty-Five Years
F.G Pearson
Chest | VOL. 89
F.G PearsonF.G Pearson
01 Apr 1986
Tumors of Childhood: A Clinical Treatise.
Philip Rubin
Archives of Pediatrics & Adolescent Medicine | VOL. 128
Philip RubinPhilip Rubin
01 Jul 1974
Lung cancer. The past twenty-five years.
F G Pearson
Chest | VOL. 89
F G PearsonF G Pearson
01 Apr 1986
A NOVEL TRANSFORMING GROWTH FACTOR IS PRESENT IN MALIGNANT ASCITES FROM HUMAN OVARIAN CARCINOMA
H W Hirte ... J Kaiser
Journal of Immunotherapy | VOL. 14
H W Hirte, et. al.H W Hirte ... J Kaiser
01 Nov 1993
View more papers

More From: Journal of Immunotherapy

Paper Title
Journal
Date
Author
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.
Haci Arak ... Şaziye Burçak Yayla
Journal of Immunotherapy | VOL. 47
Haci Arak, et. al.Haci Arak ... Şaziye Burçak Yayla
11 Mar 2024
Clinical Outcomes of PD-1/PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non-Small Cell Lung Cancer With BRAF, ERBB2/HER2, MET , or RET Alterations: A Systematic Literature Review.
Katherine G Akers ... Bin Zhao
Journal of Immunotherapy | VOL. 47
Katherine G Akers, et. al.Katherine G Akers ... Bin Zhao
19 Dec 2023
LOXL4 Shuttled by Tumor Cells-derived Extracellular Vesicles Promotes Immune Escape in Hepatocellular Carcinoma by Activating the STAT1/PD-L1 Axis.
Le Zhao ... Ruifeng Pei
Journal of Immunotherapy | VOL. 47
Le Zhao, et. al.Le Zhao ... Ruifeng Pei
04 Dec 2023
Multiple Eruptive Keratoacanthomas Secondary to Nivolumab Immunotherapy.
Eric Olsen ... Marjorie Montanez-Wiscovich
Journal of Immunotherapy | VOL. 47
Eric Olsen, et. al.Eric Olsen ... Marjorie Montanez-Wiscovich
27 Nov 2023
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.